Texas Capital Bank Wealth Management Services Inc
BankPosition in ACTU — Actuate Therapeutics, Inc.
CIK 1802655
Dallas, TX
Position in ACTU
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$156,995
-$102,186 QoQ
Shares Held
102,612
+8.5% QoQ
Ownership
0.427%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#6
of 64 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 11%
Shared 0%
None 89%
Common Shares in ACTU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Texas Capital Bank Wealth Management Services Inc holds $2,619,615 across 9 Biotechnology names. ACTU ranks #8 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CUE |
Cue Biopharma, Inc.
|
22,881 | $722,124 | |
| 2 | IRD |
Opus Genetics, Inc.
|
122,529 | $503,594 | |
| 3 | RNTX |
Rein Therapeutics, Inc.
|
300,758 | $312,787 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
3,527 | $306,672 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
429 | $213,097 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
329 | $205,144 | |
| 7 | CGTX |
Cognition Therapeutics Inc
|
143,296 | $164,790 | |
| 8 | ACTU |
Actuate Therapeutics, Inc.
This page
|
102,612 | $156,995 |
All Filings in ACTU
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $156,995 | 102,612 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $259,181 | 94,592 | Shares | Other | 2026-05-11 | |
| 2025-12-31 | $578,902 | 94,592 | Shares | Other | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||